These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23371414)

  • 21. History and perspectives of bioanalytical methods for chemical warfare agent detection.
    Black RM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1207-15. PubMed ID: 20018570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicology of organophosphorus compounds in view of an increasing terrorist threat.
    Worek F; Wille T; Koller M; Thiermann H
    Arch Toxicol; 2016 Sep; 90(9):2131-2145. PubMed ID: 27349770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External quality assessment of human biomonitoring in the range of environmental exposure levels.
    Göen T; Schaller KH; Drexler H
    Int J Hyg Environ Health; 2012 Feb; 215(2):229-32. PubMed ID: 21937272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunodetection of serum albumin adducts as biomarkers for organophosphorus exposure.
    Chen S; Zhang J; Lumley L; Cashman JR
    J Pharmacol Exp Ther; 2013 Feb; 344(2):531-41. PubMed ID: 23192655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing biological variability in livestock blood cholinesterase activity for biomonitoring organophosphate nerve agent exposure.
    Halbrook RS; Shugart LR; Watson AP; Munro NB; Linnabary RD
    J Am Vet Med Assoc; 1992 Sep; 201(5):714-25. PubMed ID: 1399773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novichoks - The A group of organophosphorus chemical warfare agents.
    Kloske M; Witkiewicz Z
    Chemosphere; 2019 Apr; 221():672-682. PubMed ID: 30677728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning.
    Dorandeu F; Mikler JR; Thiermann H; Tenn C; Davidson C; Sawyer TW; Lallement G; Worek F
    Toxicology; 2007 Apr; 233(1-3):128-44. PubMed ID: 17092624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase.
    Ghanem E; Raushel FM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):459-70. PubMed ID: 15982683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of human populations for early markers of cadmium toxicity: a review.
    Fowler BA
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary DAP metabolite levels in Thai farmers and their families and exposure to pesticides from agricultural pesticide spraying.
    Hanchenlaksh C; Povey A; O'Brien S; de Vocht F
    Occup Environ Med; 2011 Aug; 68(8):625-7. PubMed ID: 21398679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical approaches for monitoring exposure to organophosphorus and carbamate agents through analysis of protein adducts.
    Schopfer LM; Lockridge O
    Drug Test Anal; 2012; 4(3-4):246-61. PubMed ID: 22359362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrated approach to biomonitoring exposure to styrene and styrene-(7,8)-oxide using a repeated measurements sampling design.
    Fustinoni S; Campo L; Manini P; Buratti M; Waidyanatha S; De Palma G; Mutti A; Foa V; Colombi A; Rappaport SM
    Biomarkers; 2008 Sep; 13(6):560-78. PubMed ID: 18608187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE.
    van der Schans MJ; Polhuijs M; van Dijk C; Degenhardt CE; Pleijsier K; Langenberg JP; Benschop HP
    Arch Toxicol; 2004 Sep; 78(9):508-24. PubMed ID: 15170525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cases of poisoning from organophosphoric insecticides and verification method for their exposure].
    Chudoku Kenkyu; 2008 Apr; 21(2):133-40. PubMed ID: 18516937
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of genetic polymorphism in risk assessment].
    Costa LG; Lovreglio P; Vitalone A; Soleo L
    G Ital Med Lav Ergon; 2003; 25(3):320-7. PubMed ID: 14582249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in male hormone profile after occupational organophosphate exposure. A longitudinal study.
    Aguilar-Garduño C; Lacasaña M; Blanco-Muñoz J; Rodríguez-Barranco M; Hernández AF; Bassol S; González-Alzaga B; Cebrián ME
    Toxicology; 2013 May; 307():55-65. PubMed ID: 23153546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent biosensing developments in environmental security.
    Wanekaya AK; Chen W; Mulchandani A
    J Environ Monit; 2008 Jun; 10(6):703-12. PubMed ID: 18528536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure assessment at the workplace: implications of biological variability.
    Manini P; De Palma G; Mutti A
    Toxicol Lett; 2007 Feb; 168(3):210-8. PubMed ID: 17157456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinesterase activity in domestic animals as a potential biomonitor for nerve agent and other organophosphate exposure.
    Munro NB; Shugart LR; Watson AP; Halbrook RS
    J Am Vet Med Assoc; 1991 Jul; 199(1):103-15. PubMed ID: 1885319
    [No Abstract]   [Full Text] [Related]  

  • 40. Mass spectral analysis of synthones of nerve agents for verification of the Chemical Weapons Convention.
    Gupta AK; Shakya PD; Pardasani D; Palit M; Dubey DK
    Rapid Commun Mass Spectrom; 2005; 19(8):975-83. PubMed ID: 15759308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.